Close Menu

NEW YORK – Exact Sciences announced today that it has entered into a deal to acquire Genomic Health for $2.8 billion in cash and stock.

In a separate announcement, the company reported its second quarter earnings rose 94 percent year over year, due to a 93 percent increase in testing volumes from its Cologuard colorectal cancer diagnostic.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.